Richard Chin Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Chin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Chin. Richard Chin is a Director in OXIGENE INC ($OXGN) and a President and CEO in OXIGENE INC ($OXGN) and a Director in Galena Biopharma, Inc. ($GALE) and a CEO in Kindred Biosciences, Inc. ($KIN) and an Chief Executive Officer in Kindred Biosciences, Inc. ($KIN) and a President & CEO in Kindred Biosciences, Inc. ($KIN) and a President and CEO in Kindred Biosciences, Inc. ($KIN).
Address: 230 THIRD AVENUE WALTHAM, 02451 MA
Companies in which Richard Chin is an Insider
Kindred Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard Chin: Chief Executive Officer, President and CEO, President & CEO
Holdings: 1,980,853 shares
Current Value: $12,677,459
Latest Transaction: Feb 03 2021
$KIN Market Capitalization: $126.31M
$KIN Previous Close: $6.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncotelic Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard Chin: President and CEO, Director
Holdings: 60,000 shares
Latest Transaction: Aug 03 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELLAS Life Sciences Group, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard Chin: Director
Holdings: 31,339 shares
Current Value: $43,875
Latest Transaction: Oct 10 2017
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard Chin
Sentiment: All, KIN, MATN, SLS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
| Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 5.00 | 6,582 | 32,910 | 1,974,271 | 2 M to 2 M (-0.33 %) |
| Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 1,980,853 | 2 M to 2 M (+0.64 %) |
| Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 37,500 | |
| Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 13,163 | 64,894 | 1,968,353 | 2 M to 2 M (-0.66 %) |
| Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 19,744 | 97,338 | 1,981,516 | 2 M to 2 M (-0.99 %) |
| Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 2,001,260 | 2 M to 2 M (+1.91 %) |